Speaker illustration

Doctor Alexander Dietl

University Hospital Regensburg, Regensburg (Germany)

Ivabradine improves systolic ejection time in heart failure with reduced ejection fraction by heart rate-dependent and -independent mechanisms - results from the SHIfT echocardiography substudy

Event: Heart Failure 2019

Topic: Pharmacotherapy

Session: Rapid Fire 4 - Chronic heart failure - Pharmacology


Inotropes: bioenergetic consequences of omecamtiv mecarbil and levosimendan

Event: Heart Failure 2018

Topic: Cardiac Diseases

Session: Basic Science - Cardiac Diseases


Combined inhibition of the renin-angiotensin system and neprilysin enhances skeletal muscle oxidative capacity and ameliorates cachexia in tachypacing-induced heart failure

Event: Heart Failure 2018

Topic: Pathophysiology and Mechanisms, Other

Session: Chronic Heart Failure – Pathophysiology and Mechanisms


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb